Facebook
Twitter
LinkedIn
ForwardAnnual Urology Advocacy Summit Thursday (2020)
Engagement with lawmakers is more important than ever before, particularly as Congress moves forward on pandemic-related legislation that directly impacts the health care community.
Recognizing that many member advocates may not be able to travel to our nation's capital, the AUA is now bringing Washington to you later this summer with our Virtual Annual Urology Advocacy Summit! The five days of programming will begin on August 31 and will feature a virtual Hill Day of meetings with lawmakers and congressional staff on September 1.
COVID-19 will, no doubt, have a lasting impact on the practice of medicine in the United States – and your voice makes a difference! Join us to learn about how the pandemic is impacting policy, how the urology community is responding and how you can get involved.
Target Audience
- Urologists and urologic professionals within the various practice settings.
Learning Objectives
After participating in this activity, participants will be able to:
Research Advocacy
- Advocate for increased funding for urology research by the National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, and the DOD’s Congressionally Directed Medical Research Program.
- Explain the latest research into the prevention of urinary incontinence.
State Advocacy
- Explain the legislative actions state governments are attempting to mitigate the effects of the COVID-19 on healthcare providers and their patients.
Thursday, September 3, 2020
5:30 p.m. – 7:30 p.m. EDT
**Research Advocacy (pandemic’s impact on urologic research; what new research is needed moving forward)
Moderator: Aria Olumi, MD, Chair, AUA Research Council
- Endourological Society
Speaker: Dirk Lange, PhD - The Society for Basic Urologic Research
Speaker: Dolores Lamb, PhD - Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction
Speaker: Polina Reyblat, MD
**State Advocacy (pandemic’s impact on state/local level)
- AUA State Advocacy Committee
Moderator: Arthur Tarantino, MD, Chair - American Association of Clinical Urologists
Speaker: William C. Reha, MD, Chair, AACU State Advocacy Network ("Virtual Advocacy during the Pandemic and Beyond") - Mid-Atlantic Section
Speaker: Mark Fallick, MD, Member, AUA State Advocacy Committee, Chair, AUA Legislative Affairs Committee
Guest Speaker: Kimberly Horvath, JD, American Medical Association
Guest Speaker: Peter Bretan, MD, Member, AUA Public Policy Council, President, California Medical Association
**Denotes session is eligible for CME Credits.
All persons in a position to control the content of this educational activity (i.e., activity planners, speakers, moderators) were required to disclose to the provider any relevant financial relationships with any commercial interest.
ACCREDITATION:
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION:
The American Urological Association designates this live activity for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER LEARNERS:
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or AUA COI Review Work Group.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
AUA Participant Information and Policies
DISCLAIMER:
The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
AUDIO, VIDEO AND PHOTOGRAPHIC EQUIPMENT:
The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meetings.
REPRODUCTION PERMISSION:
Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.
Available Credit
- 1.75 AMA PRA Category 1 Credit™
- 1.75 Non-Physician Participation
Engagement with lawmakers is more important than ever before, particularly as Congress moves forward on pandemic-related legislation that directly impacts the health care community.
Recognizing that many member advocates may not be able to travel to our nation's capital, the AUA is now bringing Washington to you later this summer with our Virtual Annual Urology Advocacy Summit! The five days of programming will begin on August 31 and will feature a virtual Hill Day of meetings with lawmakers and congressional staff on September 1.
COVID-19 will, no doubt, have a lasting impact on the practice of medicine in the United States – and your voice makes a difference! Join us to learn about how the pandemic is impacting policy, how the urology community is responding and how you can get involved.